Skip to main content
SpringerLink
Log in

A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery

  • Originals
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Summary

The antithromboembolic efficacy of once a day low molecular weight heparin in fixed combination with dihydroergotamine (LMWH-DHE) was compared with conventional heparin-DHE in combination with Acenocoumarol (heparin-DHE/A) in 191 patients undergoing gynaecological surgery. LMWH-DHE proved equally effective in preventing thromboembolic complications, with a similar incidence of postoperative bleeding and side effects. Deep vein thrombosis occurred once in each group and one non-fatal pulmonary embolism occurred in the LMWH-DHE group. The main advantage of LMWH-DHE was significantly better patient acceptance of the single daily subcutaneous injection as compared with the two injections of conventional heparin-DHE (P=0.02). On the other hand, LMWH-DHE was associated with significantly increased incidence of intraoperative bleeding (P<0.02). The bleeding did not, however, cause any clinical problems. Discontinuation of therapy due to bleeding or pain at the site of injection occurred three times in each group. We consider the use of LMWH-DHE to be an attractive, economic and safe method of thromboembolic prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aiach M, Michaud A, Balian JL, Lefebvre M, Woler M, Fourtillan J (1983) A new low molecular weight heparin derivative. In vitro and in vivo studies. Thromb Res 31:611–621

    Google Scholar 

  2. Andersson LO, Barrowcliffe TW, Holmer E, Johnson EA, Suis GEC (1976) Anticoaculant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration. Thromb Res 9:575–583

    Google Scholar 

  3. Barrowcliffe TW, Johnson EA, Eggletou CA, Kemball-Cook G, Thomas DP (1979) Anticoagulant activities of high and low molecular weight heparin fractions. Br J Haematol 41:573–583

    Google Scholar 

  4. Bergqvist D, Hedner U, Sjorin E, Holmer E (1983) Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously. Thromb Res 32:381–391

    Google Scholar 

  5. Bergvist D, Burmark US, Frisell J, Hallböök T, Lindblad B, Risberg B, Törngren S, Wallin G (1986) Low molecular weight heparin once daily compared with conventional low dose heparin twice daily. A prospective double blind multicentre trial on prevention of postoperative thrombosis. Br J Surg 73:204–208

    Google Scholar 

  6. Björck CG, Bergqvist D, Esquivel C, Nilsson B, Rudsvik Y (1984) Effect of heparin, low molecular weight (LMWH) heparin and an analogue on experimental venous thrombosis in the rabbit. Acta Chir Scand 150:629

    Google Scholar 

  7. Bratt G, Törnebohm E, Lockner D, Bergström K (1985) A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment. Thromb Haemost 53:208–211

    Google Scholar 

  8. Cade JF, Buchanan MR, Boneu B, Ockelford P, Carter CJ, Cerskus AL, Hirsch J (1984) A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation. Thromb Res 35:613–625

    Google Scholar 

  9. Carter CJ, Kelton JG, Hirsh J, Cerskus A, Santos AV, Gent M (1982) The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood 59:1239–1245

    Google Scholar 

  10. Haas S, Fritsche HM, Hasner F, Stemberger A, Wendt P, Wolf H, Welzel D, Blümel G, Lechner F (1985) Study of the anticoagulant and antithrombotic effect of low molecular weight heparin-DHE (LMWH-DHE) in total hip replacement under double blind conditions. Thromb Haemostas 54 (1):542 (Abstract)

    Google Scholar 

  11. Harenberg J, Gnasso A, de Vries JX, Zimmermann R, Augustin J (1985) Inhibition of low molecular weight heparin by protamine chloride in vivo. Thromb Res 38:11–15

    Google Scholar 

  12. Holmer E (1980) Anticoagulant properties of heparin and heparin fractions. Scand J Haemat 36:25–39

    Google Scholar 

  13. Holmer E, Lindal U, Bäckström G, Thunberg L, Sandberg H, Söderström G, Andersson LO (1980) Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin. Thromb Res 18:861–896

    Google Scholar 

  14. Johnson EA, Kirkwood TBL, Stirling Y, Perez-Requejo JC, Ingram GIC, Baugham DR, Brozovic M (1976) Four heparin preparations. Anti-Xa potentiating effect of heparin after subcutaneous injection. Thromb Haemostas 35:586–591

    Google Scholar 

  15. Johnson EA, Mulloy B (1976) The molecular range of mucosal heparin preparations. Carbohydr Res 51:119–127

    Google Scholar 

  16. Kakkar VV, Djazaeri B, Fok J, Fletscher M, Scully MF, Westwick J (1982) low-molecular-weight heparin and prevention of postoperative deep vein thrombosis. Br Med J 284:375–379

    Google Scholar 

  17. Kakkar VV, Murray WJG (1985) Efficacy and safety of low molecular weight heparin (CY 216) in preventing postoperative venous thrombo-embolism: a cooperative study. Br J Surg 72:786–791

    Google Scholar 

  18. Kakkar VV, Stamatakis JD, Bentley PG, Lawrence D, de Haas HA, Ward VP (1979) Prophylaxis for postoperative deep vein thrombosis: synergistic effect of heparin and dihydroergotamine. J Am Med Ass 241:39–42

    Google Scholar 

  19. Koller M, Schoch U, Buchmann P, Largiadèr F, von Felten A, Frick PG (1986) Low molecular weight heparin (Kabi 2165) as thromboprophylaxis in elective visceral surgery. A randomized double-blind study versus unfractionated heparin. Thromb Haemostas 56 (1):243–246

    Google Scholar 

  20. Lam LH, Silbert JE, Rosenberg RD (1976) The separation of active and inactive forms of heparin. biochem Biophys Res Comm 69:570–577

    Google Scholar 

  21. Lane DA, Mac Gregor JE, Michalski R, Kakkar VV (1978) Anticoagulant activities of four unfractionated and fractionated heparins. Thromb Res 12:257–271

    Google Scholar 

  22. Müller-Schweinitzer E (1984) What is known about the action of dihydroergotamine on the vasculature in man? Int J Clin Pharmacol 12:677–682

    Google Scholar 

  23. Rudofsky G (1985) Nachweis der ganztägigen Wirksamkeit einer s.c. Akutgabe von Dihydroergotamin. Herz-Kreisl 11:616–619

    Google Scholar 

  24. Salzmann EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L (1980) Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 65:64–73

    Google Scholar 

  25. Sasahara AA, Koppenhagen K, Häring R, Welzel D, Wolf H (1986) Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis. Br J Surg 73:697–700

    Google Scholar 

  26. Schmitz-Hübner U, Balleisen L, Asbeck F, van der Loo J (1981) In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I: Effects of heparin fractions. Thromb Haemostas 46:612–616

    Google Scholar 

  27. Schmitz-Hübner U, Bünte H, Freise G, Reers B, Rüschemeyer C, Scherer R, Schulte H, van de Loo J (1984) Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis. Klin Wochenschr 62:349–353

    Google Scholar 

  28. Turpie AGG, Levine MN, Hirsch J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M (1986) A randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 315:925–929

    Google Scholar 

  29. Welzel D (1986) Clinical and pharmacological aspects of LMW-Heparin in the prophylaxis of thrombosis. Haemostasis 16 (S 5):196 (Abstract)

    Google Scholar 

  30. Voigt J, Hammelmann H, Hedderich J, Seifert J, Buchhammer T, Köhler A (1986) Wirksamkeit und unerwünschte Nebenwirkungen von niedermolekularem Heparin-Dihydergotamin zur Thromboembolieprophylaxe in der Abdominalchirurgie, Zentralbl Chir 111:1289–1305

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynaecology, University Hospital, CH-8091, Zürich, Switzerland

    R. A. Steiner, K. Keller & W. E. Schreiner

  2. Departments of Medicine and Research, University Hospital, Basel, Switzerland

    T. Lüscher

Authors
  1. R. A. Steiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Lüscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. E. Schreiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Statistical evaluation by Dr. U. Kreuter, Consult AG, Bern

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steiner, R.A., Keller, K., Lüscher, T. et al. A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery. Arch Gynecol Obstet 244, 141–150 (1989). https://doi.org/10.1007/BF00931291

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00931291

Key words

Search

Navigation